Io Biotech Stock Price, News & Analysis
Company Description
Io Biotech (OTC Link: IOBTQ) is a publicly traded company.
IOBTQ stock has declined 11.0% over the past year. Shares last traded at $0.0073.
On a trailing twelve-month basis, Io Biotech reported net income of -$95.5M and diluted earnings per share of $-1.45.
This page provides a comprehensive overview of IOBTQ stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Io Biotech (IOBTQ) stock last traded at $0.0073, up 9.59% from the previous close. Over the past 12 months, the stock has lost 11.0%.
IOBTQ Rankings
Latest News
SEC Filings
Io Biotech has filed 8 recent SEC filings, including 4 Form SCHEDULE 13G/A, 2 Form 25-NSE, 2 Form SCHEDULE 13D/A. The most recent filing was submitted on June 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all IOBTQ SEC filings →
Financial Highlights
operating income reached -$95.2M, and net income was -$95.5M. Diluted earnings per share stood at $-1.45. The company generated -$82.3M in operating cash flow. With a current ratio of 3.33, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Io Biotech (IOBTQ) currently stands at 636.7 thousand shares, down 13.4% from the previous reporting period, representing 0.9% of the float. Over the past 12 months, short interest has decreased by 13.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Io Biotech (IOBTQ) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.